(Q43828249)

English

Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Candida albicans

1 reference

based on heuristic

inferred from title

5-fluorocytosine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Cryptococcus neoformans

1 reference

based on heuristic

inferred from title

Russell E. Lewis

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Keele DJ

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

DeLallo VC

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ernst EJ

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Klepser ME

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

121-126

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of systemic antifungal drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of Candida infections: susceptibility testing, resistance, and therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies in the treatment of systemic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amphotericin B use in a community hospital, with special emphasis on side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Method of reliable determination of minimal lethal antibiotic concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions in vitro between polyenes and imidazoles against yeasts

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900297-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(01)00297-8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43828249&oldid=2103702875"